Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers
EMV De Cuba, R Kwakman, M Van Egmond… - Virchows Archiv, 2012 - Springer
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …
[引用][C] Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future possibilities for personalised treatment by use of biomarkers
EMV DE CUBA, R KWAKMAN… - Virchows …, 2012 - pascal-francis.inist.fr
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future
possibilities for personalised treatment by use of biomarkers CNRS Inist Pascal-Francis CNRS …
possibilities for personalised treatment by use of biomarkers CNRS Inist Pascal-Francis CNRS …
[引用][C] Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
EMV de Cuba, R Kwakman… - Virchows …, 2012 - researchinformation.amsterdamumc …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer —
Amsterdam UMC research portal Skip to main navigation Skip to search Skip to main content …
Amsterdam UMC research portal Skip to main navigation Skip to search Skip to main content …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer.
E Cuba, R Kwakman, M Egmond… - Virchows Archiv …, 2012 - search.ebscohost.com
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
EMV Cuba, R Kwakman, M Egmond, LJW Bosch… - Virchows Archiv, 2012 - infona.pl
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers
EMV de Cuba, R Kwakman… - Virchows Archiv …, 2012 - pubmed.ncbi.nlm.nih.gov
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers.
EM de Cuba, R Kwakman, M van Egmond… - Virchows Archiv: an …, 2012 - europepmc.org
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
V de Cuba, R Kwakman, M van Egmond… - Virchows …, 2012 - search.proquest.com
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
circulation. In addition, 10-25% of CRC patients eventually show metastases in the …
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
EMV Cuba, R Kwakman, M Egmond, LJW Bosch… - Virchows Archiv, 2012 - infona.pl
When colorectal cancer (CRC) metastasizes, this is mostly to the liver via the portal
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …
circulation. In addition, 10–25% of CRC patients eventually show metastases in the …